Brain on Fire: Incentive Salience, Hedonic Hot Spots, Dopamine, Obesity, and Other Hunger Games

Annual Review of Nutrition

Volumn 37, Issue , 2017, Pages 183-205

  Cameron, Jameason D ^a   Chaput, Jean Philippe ^a   Sjödin, Anders M ^b   Goldfield, Gary S ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BMI; Energy intake; FMRI; Food addiction; Food reward; Liking; Obesity surgery

Indexed keywords

DOPAMINE;

ANIMAL; BRAIN; FEEDING BEHAVIOR; HUMAN; METABOLISM; MOTIVATION; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DOPAMINE; FEEDING BEHAVIOR; HUMANS; MOTIVATION; OBESITY;

EID: 85027052929     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071816-064855     Document Type: Review

References (127)

1. Am. Psychiatr. Assoc. 2000. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Washington, DC: APA
2. Am. Psychiatr. Assoc. 2013. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: APA
3. Appel L, Bergstrom M, Buus Lassen J, Langstrom B. 2014. Tesofensine, a novel triple monoamine reuptake inhibitor with anti-obesity effects: Dopamine transporter occupancy as measured by PET. Eur. Neuropsychopharmacol. 24:251-61
4. Avena NM, Hoebel BG. 2003. A diet promoting sugar dependency causes behavioral cross-sensitization to a low dose of amphetamine. Neuroscience 122:17-20
5. Axel AM, Mikkelsen JD, Hansen HH. 2010. Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of ?1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat. Neuropsychopharmacology 35:1464-76
6. Benton D, Young HA. 2016. A meta-analysis of the relationship between brain dopamine receptors and obesity: A matter of changes in behavior rather than food addiction? Int. J. Obes. 40(Suppl. 1):S12-21
7. Berridge KC. 1996. Food reward: Brain substrates of wanting and liking. Neurosci. Biobehav. Rev. 20:1-25
8. Berridge KC, Kringelbach ML. 2015. Pleasure systems in the brain. Neuron 86:646-64
9. Berridge KC, Robinson TE. 1998. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res. Rev. 28:309-69
10. Berthoud HR. 2002. Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev. 26:393-428
11. Berthoud HR. 2004. Mind versus metabolism in the control of food intake and energy balance. Physiol. Behav. 81:781-93
12. Berthoud HR. 2007. Interactions between the "cognitive" and "metabolic" brain in the control of food intake. Physiol. Behav. 91:486-98
13. Berthoud HR, Morrison C. 2008. The brain, appetite, and obesity. Annu. Rev. Psychol. 59:55-92
14. Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, et al. 2000. Reward deficiency syndrome: A biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoact. Drugs 32(Suppl.):i-iv, 1-112
15. Blum K, Braverman ER, Wood RC, Gill J, Li C, et al. 1996. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: A preliminary report. Pharmacogenetics 6:297-305
16. Blundell JE. 1992. Psychobiology of the appetite. J. Annu. Diabetol. Hotel-Dieu 1992:239-53
17. Blundell JE, Finlayson G. 2011. Food addiction not helpful: The hedonic component-implicit wanting-is important. Addiction 106:1216-18.
18. Discussion. 2011. Addiction 106:1219-20
19. Blundell JE, Stubbs RJ, Golding C, Croden F, Alam R, et al. 2005. Resistance and susceptibility to weight gain: Individual variability in response to a high-fat diet. Physiol. Behav. 86:614-22
20. Cameron J, Doucet E. 2007. Getting to the bottom of feeding behaviour: Who's on top? Appl. Physiol. Nutr. Metab. 32:177-89
21. Cameron JD, Doucet E. 2011. Reinforcement and food hedonics: A look at how energy deprivation impacts food reward. In Handbook of Behavior, Food and Nutrition, ed. CR Martin, VR Preedy, RR Watson, pp. 2285-305. New York: Springer
22. Cameron JD, Riou MÈ, Tesson F, Goldfield GS, Rabasa-Lhoret R, et al. 2013. The Taq IA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. Appetite 60:111-16
23. Carr KD. 2007. Chronic food restriction: Enhancing effects on drug reward and striatal cell signaling. Physiol. Behav. 91:459-72
24. Carter A, Hendrikse J, Lee N, Yucel M, Verdejo-Garcia A, et al. 2016. The neurobiology of "food addiction" and its implications for obesity treatment and policy. Annu. Rev. Nutr. 36:105-28
25. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. 1993. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem. Med. Metab. Biol. 50:176-85
26. Cornelis MC, Flint A, Field AE, Kraft P, Han J, et al. 2016. A genome-wide investigation of food addiction. Obesity 24:1336-41
27. Davis C. 2013. A narrative review of binge eating and addictive behaviors: Shared associations with seasonality and personality factors. Front. Psychiatry 4:183
28. Davis C. 2015. The epidemiology and genetics of binge eating disorder (BED). CNS Spectr. 20:522-29
29. Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy JL. 2011. Evidence that 'food addiction' is a valid phenotype of obesity. Appetite 57:711-17
30. Davis C, Fox J. 2008. Sensitivity to reward and body mass index (BMI): Evidence for a non-linear relationship. Appetite 50:43-49
31. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, et al. 2007. Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology 32:2199-206
32. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, et al. 2008. Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 32:620-28
33. Davis C, Levitan RD, Kaplan AS, Carter-Major JC, Kennedy JL. 2016. Sex differences in subjective and objective responses to a stimulantmedication (methylphenidate): Comparisons between overweight/obese adults with and without binge-eating disorder. Int. J. Eat. Disord. 49:473-81
34. Davis C, Levitan RD, Kaplan AS, Kennedy JL, Carter JC. 2014. Food cravings, appetite, and snack-food consumption in response to a psychomotor stimulant drug: The moderating effect of "food-addiction." Front. Psychol. 5:403
35. Davis C, Strachan S, Berkson M. 2004. Sensitivity to reward: Implications for overeating and overweight. Appetite 42:131-38
36. de Araujo IE, Geha P, Small DM. 2012. Orosensory and homeostatic functions of the insular taste cortex. Chemosens. Percept. 5:64-79
37. De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, et al. 2011. The gut hormones PYY3-36 and GLP-17-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 14:700-6
38. de Weijer BA, van de Giessen E, van Amelsvoort TA, Boot E, Braak B, et al. 2011. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res. 1:37
39. Demos KE, Heatherton TF, Kelley WM. 2012. Individual differences in nucleus accumbens activity to food and sexual images predict weight gain and sexual behavior. J. Neurosci. 32:5549-52
40. Drummond DC, Cooper T, Glautier SP. 1990. Conditioned learning in alcohol dependence: Implications for cue exposure treatment. Br. J. Addict. 85:725-43
41. Dunn JP, Kessler RM, Feurer ID, Volkow ND, Patterson BW, et al. 2012. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care 35:1105-11
42. Epstein LH, Dearing KK, Erbe RW. 2010. Parent-child concordance of Taq1 A1 allele predicts similarity of parent-child weight loss in behavioral family-based treatment programs. Appetite 55:363-66
43. Epstein LH, Leddy JJ, Temple JL, Faith MS. 2007. Food reinforcement and eating: A multilevel analysis. Psychol. Bull. 133:884-906
44. Epstein LH, Temple JL, Neaderhiser BJ, Salis RJ, Erbe RW, Leddy JJ. 2007. Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behav. Neurosci. 121:877-86
45. Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk LW Jr., et al. 2004. Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am. J. Clin. Nutr. 80:82-88
46. Farr OM, Li CS, Mantzoros CS. 2016. Central nervous system regulation of eating: Insights from human brain imaging. Metabolism 65:699-713
47. Farr OM, Sofopoulos M, Tsoukas MA, Dincer F, Thakkar B, et al. 2016. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: A crossover, randomised, placebo-controlled trial. Diabetologia 59:954-65
48. Field M, Mogg K, Bradley BP. 2004. Eye movements to smoking-related cues: Effects of nicotine deprivation. Psychopharmacology 173:116-23
49. Franken IH, Kroon LY, Wiers RW, Jansen A. 2000. Selective cognitive processing of drug cues in heroin dependence. J. Psychopharmacol. 14:395-400
50. Franz MJ, Van Wormer JJ, Crain AL, Boucher JL, Histon T, et al. 2007. Weight-loss outcomes: A systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J. Am. Diet. Assoc. 107:1755-67
51. Garrido E, Palomo T, Ponce G, Garcia-Consuegra I, Jimenez-Arriero MA, Hoenicka J. 2010. The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine. Neurotox. Res. 20:32-39
52. Gearhardt AN, Brownell KD. 2013. Can food and addiction change the game? Biol. Psychiatry 73:802-3
53. Gearhardt AN, Corbin WR, Brownell KD. 2009. Preliminary validation of the Yale Food Addiction Scale. Appetite 52:430-36
54. Geha PY, Aschenbrenner K, Felsted J, O'Malley SS, Small DM. 2013. Altered hypothalamic response to food in smokers. Am. J. Clin. Nutr. 97:15-22
55. Goldfield GS, Dowler LM, Walker M, Cameron JD, Ferraro ZM, et al. 2013. Are dopamine-related genotypes risk factors for excessive gestational weight gain? Int. J. Women's Health 5:253-59
56. Goldfield GS, Lorello C, Cameron J, Chaput JP. 2011. Gender differences in the effects of methylphenidate on energy intake in young adults: A preliminary study. Appl. Physiol. Nutr. Metab. 36:1009-13
57. Goldfield GS, Lorello C, Doucet E. 2007. Methylphenidate reduces energy intake and dietary fat intake in adults: A mechanism of reduced reinforcing value of food? Am. J. Clin. Nutr. 86:308-15
58. Green E, Jacobson A, Haase L, Murphy C. 2011. Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults. Brain Res. 1386:109-17
59. Hankir MK, Ashrafian H, Hesse S, Horstmann A, Fenske WK. 2015. Distinctive striatal dopamine signaling after dieting and gastric bypass. Trends Endocrinol. Metab. 26:223-30
60. Hansen HH, Jensen MM, Overgaard A, Weikop P, Mikkelsen JD. 2013. Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat. Pharmacol. Biochem. Behav. 110:265-71
61. Havel PJ. 2001. Peripheral signals conveying metabolic information to the brain: Short-term and longterm regulation of food intake and energy homeostasis. Exp. Biol. Med. 226:963-77
62. Hebebrand J, Albayrak O, Adan R, Antel J, Dieguez C, et al. 2014. "Eating addiction, " rather than "food addiction, " better captures addictive-like eating behavior. Neurosci. Biobehav. Rev. 47:295-306
63. Horstmann A, Fenske WK, Hankir MK. 2015. Argument for a non-linear relationship between severity of human obesity and dopaminergic tone. Obes. Rev. 16:821-30
64. Hoy SM. 2013. Lorcaserin: A review of its use in chronic weight management. Drugs 73:463-73
65. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzle AG, et al. 2014. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation 129:S102-38
66. Johnson PM, Kenny PJ. 2010. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci. 13:635-41
67. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, et al. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4:290-96
68. Kelley AE, Baldo BA, Pratt WE, Will MJ. 2005. Corticostriatal-hypothalamic circuitry and food motivation: Integration of energy, action and reward. Physiol. Behav. 86:773-95
69. Kessler RM, Zald DH, Ansari MS, Li R, Cowan RL. 2014. Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity. Synapse 68:317-20
70. Kiyatkin EA, Gratton A. 1994. Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food. Brain Res. 652:225-34
71. Koob GF, Le Moal M. 2008. Review.Neurobiological mechanisms for opponentmotivational processes in addiction. Philos. Trans. R. Soc. B 363:3113-23
72. Koob GF, Volkow ND. 2009. Neurocircuitry of addiction. Neuropsychopharmacology 35:217-38
73. Kringelbach ML, Rolls ET. 2004. The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 72:341-72
74. Leddy JJ, Epstein LH, Jaroni JL, Roemmich JN, Paluch RA, et al. 2004. Influence of methylphenidate on eating in obese men. Obes. Res. 12:224-32
75. Li S, Zhao JH, Luan J, Luben RN, Rodwell SA, et al. 2010. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am. J. Clin. Nutr. 91:184-90
76. Liang J, Matheson BE, Kaye WH, Boutelle KN. 2014. Neurocognitive correlates of obesity and obesityrelated behaviors in children and adolescents. Int. J. Obes. 38:494-506
77. Long CG, Blundell JE, Finlayson G. 2015. A systematic review of the application and correlates of YFAS-diagnosed 'food addiction' in humans: Are eating-related 'addictions' a cause for concern or empty concepts? Obes. Facts 8:386-401
78. Lutter M, Nestler EJ. 2009. Homeostatic and hedonic signals interact in the regulation of food intake. J. Nutr. 139:629-32
79. Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, et al. 2012. Deficits in dopamine D2 receptors and presynaptic dopamine in heroin dependence: Commonalities and differences with other types of addiction. Biol. Psychiatry 71:192-98
80. Miras AD, Jackson RN, Jackson SN, Goldstone AP, Olbers T, et al. 2012. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am. J. Clin. Nutr. 96:467-73
81. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: From structure to function. Physiol. Rev. 78:189-225
82. Munzberg H, Laque A, Yu S, Rezai-Zadeh K, Berthoud HR. 2015. Appetite and body weight regulation after bariatric surgery. Obes. Rev. 16(Suppl. 1):77-90
83. Narayanaswami V, Dwoskin LP. 2016. Obesity: Current and potential pharmacotherapeutics and targets. Pharmacol. Ther. 170:116-47
84. Need AC, Ahmadi KR, Spector TD, Goldstein DB. 2006. Obesity is associated with genetic variants that alter dopamine availability. Ann. Hum. Genet. 70:293-303
85. Neville MJ, Johnstone EC, Walton RT. 2004. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum. Mutat. 23:540-45
86. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, et al. 2013. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study. Lancet 384:766-81
87. Nikolova YS, Ferrell RE, Manuck SB, Hariri AR. 2011. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 36:1940-47
88. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. 1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch. Gen. Psychiatry 48:648-54
89. Nolan LJ, Geliebter A. 2016. "Food addiction" is associated with night eating severity. Appetite 98:89-94
90. O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ. 2004. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 304:452-54
91. Ochner CN, Laferrere B, Afifi L, Atalayer D, Geliebter A, Teixeira J. 2012. Neural responsivity to food cues in fasted and fed states pre and post gastric bypass surgery. Neurosci. Res. 74:138-43
92. Ochner CN, Stice E, Hutchins E, Afifi L, Geliebter A, et al. 2012. Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery. Neuroscience 209:128-35
93. Olbers T, Bjorkman S, Lindroos A, Maleckas A, Lonn L, et al. 2006. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: A randomized clinical trial. Ann. Surg. 244:715-22
94. Palmiter RD. 2007. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci. 30:375-81
95. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, et al. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry 3:256-60
96. Randolph TG. 1956. The descriptive features of food addiction; addictive eating and drinking. Q. J. Stud. Alcohol. 17:198-224
97. Ratsma JE, van der Stelt O, Schoffelmeer ANM, Westerveld A, Boudewijn Gunning W. 2001. P3 eventrelated potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics. Alcohol. Clin. Exp. Res. 25:960-67
98. Ravussin E, Kozak LP. 2004. Energy homeostasis. In Pharmacotherapy of Obesity: Options and Alternatives, ed. KG Hofbauer, U Keller, O Boss, pp. 3-23. Boca Raton, FL: CRC Press
99. Robinson TE, Berridge KC. 2008. The incentive sensitization theory of addiction: Some current issues. Philos. Trans. R. Soc. B 363:3137-46
100. Saelens BE, Epstein LH. 1996. Reinforcing value of food in obese and non-obese women. Appetite 27:41-50
101. Salamone JD, Correa M. 2002. Motivational views of reinforcement: Implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav. Brain Res. 137:3-25
102. Salamone JD, Correa M. 2013. Dopamine and food addiction: Lexicon badly needed. Biol. Psychiatry 73:e15-24
103. Salgado S, Kaplitt MG. 2015. The nucleus accumbens: A comprehensive review. Stereotact. Funct. Neurosurg. 93:75-93
104. Scheid JL, Carr KA, Lin H, Fletcher KD, Sucheston L, et al. 2014. FTO polymorphisms moderate the association of food reinforcement with energy intake. Physiol. Behav. 132:51-56
105. Schmidt JB, Pedersen SD, Gregersen NT, Vestergaard L, Nielsen MS, et al. 2016. Effects of RYGB on energy expenditure, appetite and glycaemic control: A randomized controlled clinical trial. Int. J. Obes. 40:281-90
106. Scholtz S, Goldstone AP, le Roux CW. 2015. Changes in reward after gastric bypass: The advantages and disadvantages. Curr. Atheroscler. Rep. 17:61
107. Scholtz S, Miras AD, Chhina N, Prechtl CG, Sleeth ML, et al. 2014. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 63:891-902
108. Schultz W, Apicella P, Ljungberg T. 1993. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 13:900-13
109. Seeley RJ, Berridge KC. 2015. The hunger games. Cell 160:805-6
110. Skibicka KP. 2013. The central GLP-1: Implications for food and drug reward. Front. Neurosci. 7:181
111. Small DM, Jones-Gotman M, Dagher A. 2003. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuro Image 19:1709-15
112. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M. 2001. Changes in brain activity related to eating chocolate: From pleasure to aversion. Brain 124:1720-33
113. Smith DG, Robbins TW. 2013. The neurobiological underpinnings of obesity and binge eating: A rationale for adopting the food addiction model. Biol. Psychiatry 73:804-10
114. Smith JA, Epstein LH. 1991. Behavioral economic analysis of food choice in obese children. Appetite 17:91-95
115. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al. 2010. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42:937-48
116. Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO, et al. 2010. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes. Surg. 20:369-74
117. Steffen KJ, Engel SG, Wonderlich JA, Pollert GA, Sondag C. 2015. Alcohol and other addictive disorders following bariatric surgery: Prevalence, risk factors and possible etiologies. Eur. Eat. Disord. Rev. 23:442-50
118. Stice E, Burger KS, Yokum S. 2013. Relative ability of fat and sugar tastes to activate reward, gustatory, and somatosensory regions. Am. J. Clin. Nutr. 98:1377-84
119. Stice E, Burger KS, Yokum S. 2015. Reward region responsivity predicts future weight gain and moderating effects of the Taq IA allele. J. Neurosci. 35:10316-24
120. Stice E, Figlewicz DP, Gosnell BA, Levine AS, Pratt WE. 2013. The contribution of brain reward circuits to the obesity epidemic. Neurosci. Biobehav. Rev. 37:2047-58
121. Stice E, Spoor S, Bohon C, Small DM. 2008. Relation between obesity and blunted striatal response to food is moderated by Taq IA1 gene. Science 322:449-52
122. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. 2008. Relation of reward from food intake and anticipated food intake to obesity: A functional magnetic resonance imaging study. J. Abnorm. Psychol. 117:924-35
123. Stice E, Yokum S. 2016. Neural vulnerability factors that increase risk for future weight gain. Psychol. Bull. 142:447-71
124. Stunkard AJ, Foch TT, Hrubec Z. 1986. A twin study of human obesity. JAMA 256:51-54
125. Sun X, Kroemer NB, Veldhuizen MG, Babbs AE, de Araujo IE, et al. 2015. Basolateral amygdala response to food cues in the absence of hunger is associated with weight gain susceptibility. J. Neurosci. 35:7964-76
126. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, et al. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479-84
127. US Food Drug Admin. 2015. FDA expands uses of Vyvanse to treat binge-eating disorder. FDANews Release, Jan. 30. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm432543.htm